Catalent
CTLT
#1496
Rank
NZ$20.37 B
Marketcap
$112.25
Share price
0.00%
Change (1 day)
63.75%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Market cap: NZ$20.37 Billion

As of December 2024 Catalent has a market cap of NZ$20.37 Billion. This makes Catalent the world's 1496th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$20.37 B58.75%
2023NZ$12.83 B0.59%
2022NZ$12.75 B-61.97%
2021NZ$33.55 B41.24%
2020NZ$23.75 B94.1%
2019NZ$12.23 B80.8%
2018NZ$6.76 B-11.92%
2017NZ$7.68 B58.28%
2016NZ$4.85 B6.62%
2015NZ$4.55 B3.37%
2014NZ$4.40 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Catalent was reported to be:

NZ$20.37 Billion
by Yahoo Finance info icon info icon
NZ$20.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$3.45 B-83.02%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.33 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.14 B-35.48%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
NZ$1.40 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA